Medicinal preparation particularly for the treatment of slipped discs hernias

Abstract

The invention concerns a product consisting in an injection medicinal formulations comprising at least one compound to provide a viscous formulation, ethanol and at least tungsten and/or tantalum metal making said formulation opaque to X rays so as to control its delivery and its action. Said formulation is in particular useful for treating herniated invertebral discs but also in intervention having demonstrated the efficacy of pure ethanol: treatment of hepatocellular tumours or osteoid osteomas, renal cysts and arterial-veinous angiomas.

What is claimed is: 
     
         1 . A method for the treatment of disc hernias comprising a step of administering, to a patient in need thereof, a viscous non-toxic preparation comprising:
 (1) ethanol,   (2) ethyl cellulose at a concentration ranging from 0.5% to 15% by weight of the total weight of the preparation, and   (3) at least one inert compound making the preparation opaque to X-rays,   wherein the ethanol and the ethyl cellulose form a homogenous mixture.   
     
     
         2 . The method of  claim 1  wherein the inert compound making the preparation opaque to X-rays is a material based on tungsten, tantalum or both tungsten and tantalum. 
     
     
         3 . The method of  claim 2  wherein the inert compound making the preparation opaque to X-rays is a tungsten and/or tantalum metal. 
     
     
         4 . The method according to  claim 3 , wherein the amount of tungsten and/or tantalum metal ranges from 1% to 35% based on the total weight of the preparation. 
     
     
         5 . The method according to  claim 1 , wherein ethylcellulose is at a concentration ranging from 1.22% to 5.88% by weight of the total weight of the preparation. 
     
     
         6 . The method according to  claim 1 , wherein the said compound making the said preparation opaque to X-rays consists of a tungsten metal. 
     
     
         7 . The method according to  claim 1 , wherein ethanol has purity ranging from 70% to 99% (v/v). 
     
     
         8 . The method according to  claim 7 , wherein ethanol has a purity of 95% (v/v). 
     
     
         9 . The method according to  claim 1 , wherein the said viscous non-toxic preparation is administered by injection. 
     
     
         10 . The method according to  claim 1 , wherein the said viscous non-toxic preparation is administered by intradiscal injection, whereby causing a decreased intradiscal pressure. 
     
     
         11 . The method according to  claim 2 , wherein ethylcellulose is at a concentration ranging from 1.22% to 5.88% by weight of the total weight of the preparation. 
     
     
         12 . The method according to  claim 4 , wherein the said compound making the said preparation opaque to X-rays consists of a tungsten metal. 
     
     
         13 . The method according to  claim 2 , wherein ethanol has purity ranging from 70% to 99% (v/v). 
     
     
         14 . The method according to  claim 2 , wherein ethanol has a purity of 95% (v/v). 
     
     
         15 . The method of  claim 4  wherein the inert compound making the preparation opaque to X-rays is a tungsten and/or tantalum metal. 
     
     
         16 . The method of  claim 3 , wherein ethylcellulose is at a concentration ranging from 1.22% to 5.88% by weight of the total weight of the preparation. 
     
     
         17 . The method of  claim 3 , wherein the said compound making the said preparation opaque to X-rays consists of a tungsten metal. 
     
     
         18 . The method of  claim 3 , wherein ethanol has purity ranging from 70% to 99% (v/v). 
     
     
         19 . The method of  claim 3 , wherein the said viscous non-toxic preparation is administered by injection. 
     
     
         20 . The method of  claim 3 , wherein the said viscous non-toxic preparation is administered by intradiscal injection, whereby causing a decreased intradiscal pressure.